Adtalem Global Education (NYSE:CVSA) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Adtalem Global Education (NYSE:CVSA) from a hold rating to a buy rating in a research report sent to investors on Saturday morning.

CVSA has been the subject of several other research reports. Barrington Research reissued an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial lifted their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Trading Down 8.4%

Adtalem Global Education stock opened at $129.15 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market cap of $4.39 billion, a price-to-earnings ratio of 18.35, a P/E/G ratio of 1.05 and a beta of 0.62. The stock’s 50-day moving average is $124.82. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Research analysts anticipate that Adtalem Global Education will post 8.95 EPS for the current fiscal year.

Insider Transactions at Adtalem Global Education

In related news, SVP Douglas G. Beck sold 2,439 shares of the company’s stock in a transaction on Wednesday, July 8th. The shares were sold at an average price of $135.34, for a total value of $330,094.26. Following the completion of the transaction, the senior vice president directly owned 33,070 shares of the company’s stock, valued at approximately $4,475,693.80. This represents a 6.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 2,529 shares of the stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $130.78, for a total value of $330,742.62. Following the transaction, the chief executive officer owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. This trade represents a 0.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 15,694 shares of company stock valued at $2,098,614 over the last quarter. Corporate insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.